Bruker releases SARS-CoV-2 mutation assay

2021 04 27 22 24 2298 Nasal Swab Test 400

Bruker has released a new SARS-CoV-2 assay that detects mutations to the virus.

FluoroType SARS-CoV-2 varID Q assay is a LiquidArray mid-plex polymerase chain reaction (PCR) panel that uses nasal and oral swabs. It can detect a variety of mutations to the SARS-CoV-2 virus with a sensitivity of 98% and a specificity of 100%, according to the firm.

In addition to the original Wuhan strain, the test can identify the following mutations:

  • B.1.1.7 (U.K.)
  • B.1.525 (Nigeria)
  • B.1.351 (South Africa)
  • P.1 (Brazil)
  • B.1.1.298 (Denmark)

It is CE-IVD marked, the company said.

The FluoroCycler XT PCR system for mid-plex LiquidArray assays. Image courtesy of Bruker.The FluoroCycler XT PCR system for mid-plex LiquidArray assays. Image courtesy of Bruker.
Page 1 of 21
Next Page